Weighted Average Number of Shares Outstanding, Basic of ALPINE IMMUNE SCIENCES, INC. from 30 Sep 2016 to 31 Mar 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
ALPINE IMMUNE SCIENCES, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Sep 2016 to 31 Mar 2024.
  • ALPINE IMMUNE SCIENCES, INC. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Mar 2024 was 64,033,018, a 35% increase year-over-year.
  • ALPINE IMMUNE SCIENCES, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 50,000,339, a 50% increase from 2022.
  • ALPINE IMMUNE SCIENCES, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 33,435,280, a 31% increase from 2021.
  • ALPINE IMMUNE SCIENCES, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 25,476,889, a 22% increase from 2020.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

ALPINE IMMUNE SCIENCES, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 64,033,018 +16,464,869 +35% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 50,000,339 +16,565,059 +50% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2024 2023 FY
Q3 2023 49,222,344 +17,647,986 +56% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 48,049,936 +17,725,003 +58% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 47,568,149 +17,300,677 +57% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 33,435,280 +7,958,391 +31% 01 Oct 2022 31 Dec 2022 10-K 20 Mar 2024 2023 FY
Q3 2022 31,574,358 +6,849,916 +28% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 30,324,933 +6,416,417 +27% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 30,267,472 +6,397,612 +27% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 25,476,889 01 Oct 2021 31 Dec 2021 10-K 20 Mar 2024 2023 FY
Q3 2021 24,724,442 +2,447,296 +11% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 23,908,516 +5,319,523 +29% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 23,869,860 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q3 2020 22,277,146 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 18,588,993 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021 2021 Q2
Q3 2018 13,851,336 +3,273,564 +31% 01 Jul 2018 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q3 2017 10,577,772 +9,969,071 +1638% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018 2018 Q3
Q3 2016 608,701 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q3

ALPINE IMMUNE SCIENCES, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 50,000,339 +16,565,059 +50% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2024 2023 FY
2022 33,435,280 +7,958,391 +31% 01 Jan 2022 31 Dec 2022 10-K 20 Mar 2024 2023 FY
2021 25,476,889 +4,650,423 +22% 01 Jan 2021 31 Dec 2021 10-K 20 Mar 2024 2023 FY
2020 20,826,466 +2,467,602 +13% 01 Jan 2020 31 Dec 2020 10-K 23 Mar 2023 2022 FY
2019 18,358,864 01 Jan 2019 31 Dec 2019 10-K 17 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.